Advertisement
Letter to the Editor| Volume 55, ISSUE 3, P202-204, September 2009

Circulating levels of adiponectin, oxidized LDL and C-reactive protein in Portuguese patients with psoriasis vulgaris, according to body mass index, severity and duration of the disease

  • Susana Coimbra
    Correspondence
    Corresponding authors at: Serviço de Bioquímica, Faculdade de Farmácia da Universidade do Porto, R Aníbal Cunha 164, 4050-047 Porto, Portugal. Tel.: +351962677495; fax: +351222003977.
    Affiliations
    Faculdade de Farmácia, Serviço de Bioquímica, Universidade do Porto, Porto, Portugal

    Instituto de Biologia Molecular e Celular (IBMC), Universidade do Porto, Porto, Portugal

    Centro de Investigação das Tecnologias da Saúde (CITS) – Instituto Politécnico da Saúde Norte, Gandra-Paredes, Portugal
    Search for articles by this author
  • Hugo Oliveira
    Affiliations
    Serviço de Dermatologia, Hospitais da Universidade de Coimbra, Coimbra, Portugal
    Search for articles by this author
  • Flávio Reis
    Affiliations
    Instituto de Farmacologia e Terapêutica Experimental, IBILI, Faculdade de Medicina, Universidade de Coimbra, Coimbra, Portugal
    Search for articles by this author
  • Luís Belo
    Affiliations
    Faculdade de Farmácia, Serviço de Bioquímica, Universidade do Porto, Porto, Portugal

    Instituto de Biologia Molecular e Celular (IBMC), Universidade do Porto, Porto, Portugal
    Search for articles by this author
  • Susana Rocha
    Affiliations
    Faculdade de Farmácia, Serviço de Bioquímica, Universidade do Porto, Porto, Portugal

    Instituto de Biologia Molecular e Celular (IBMC), Universidade do Porto, Porto, Portugal
    Search for articles by this author
  • Alexandre Quintanilha
    Affiliations
    Instituto de Biologia Molecular e Celular (IBMC), Universidade do Porto, Porto, Portugal

    Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto, Porto, Portugal
    Search for articles by this author
  • Américo Figueiredo
    Affiliations
    Serviço de Dermatologia, Hospitais da Universidade de Coimbra, Coimbra, Portugal
    Search for articles by this author
  • Frederico Teixeira
    Affiliations
    Instituto de Farmacologia e Terapêutica Experimental, IBILI, Faculdade de Medicina, Universidade de Coimbra, Coimbra, Portugal
    Search for articles by this author
  • Elisabeth Castro
    Affiliations
    Faculdade de Farmácia, Serviço de Bioquímica, Universidade do Porto, Porto, Portugal

    Instituto de Biologia Molecular e Celular (IBMC), Universidade do Porto, Porto, Portugal
    Search for articles by this author
  • Petronila Rocha-Pereira
    Affiliations
    Instituto de Biologia Molecular e Celular (IBMC), Universidade do Porto, Porto, Portugal

    Centro de Investigação em Ciências da Saúde (CICS), Universidade da Beira Interior, Covilhã, Portugal
    Search for articles by this author
  • Author Footnotes
    1 Serviço de Bioquímica, Faculdade de Farmácia da Universidade do Porto, R Aníbal Cunha 164, 4050-047 Porto. Tel.: +351222078907; fax: +351222003977.
    Alice Santos-Silva
    Correspondence
    Corresponding authors at: Serviço de Bioquímica, Faculdade de Farmácia da Universidade do Porto, R Aníbal Cunha 164, 4050-047 Porto, Portugal. Tel.: +351962677495; fax: +351222003977.
    Footnotes
    1 Serviço de Bioquímica, Faculdade de Farmácia da Universidade do Porto, R Aníbal Cunha 164, 4050-047 Porto. Tel.: +351222078907; fax: +351222003977.
    Affiliations
    Faculdade de Farmácia, Serviço de Bioquímica, Universidade do Porto, Porto, Portugal

    Instituto de Biologia Molecular e Celular (IBMC), Universidade do Porto, Porto, Portugal
    Search for articles by this author
  • Author Footnotes
    1 Serviço de Bioquímica, Faculdade de Farmácia da Universidade do Porto, R Aníbal Cunha 164, 4050-047 Porto. Tel.: +351222078907; fax: +351222003977.
      Psoriasis vulgaris, a chronic inflammatory disease, associates with oxidative stress, dislipidaemia, overweight/obesity, low adiponectin levels and a high frequency in cardiovascular diseases (CVD) [
      • Rocha-Pereira P.
      • Santos-Silva A.
      • Rebelo I.
      • Figueiredo A.
      • Quintanilha A.
      • Teixeira F.
      Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease.
      ,
      • Vanizor Kural B.
      • Orem A.
      • Cimsit G.
      • Yandi Y.E.
      • Calapoglu M
      Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis.
      ,
      • Sterry W.
      • Strober B.E.
      • Menter A
      Obesity in psoriasis: the metabolic, clinical and therapeutic implications Report of an interdisciplinary conference and review.
      ,
      • Kaur S.
      • Zilmer K.
      • Kairane C.
      • Kals M.
      • Zilmer M
      Clear differences in adiponectin level and glutathione redox status revealed in obese and normal-weight patients with psoriasis.
      ,
      • Takahashi H.
      • Tsuji H.
      • Takahashi I.
      • Hashimoto Y.
      • Ishida-Yamamoto A.
      • Iizuka H.
      Plasma adiponectin and leptin levels in Japanese patients with psoriasis.
      ]. However, there are no reports studying the relation of CVD risk factors with body mass index (BMI), severity and duration of psoriasis.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Dermatological Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rocha-Pereira P.
        • Santos-Silva A.
        • Rebelo I.
        • Figueiredo A.
        • Quintanilha A.
        • Teixeira F.
        Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease.
        Clin Chim Acta. 2001; 303: 33-39
        • Vanizor Kural B.
        • Orem A.
        • Cimsit G.
        • Yandi Y.E.
        • Calapoglu M
        Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis.
        Clin Chim Acta. 2003; 328: 71-82
        • Sterry W.
        • Strober B.E.
        • Menter A
        Obesity in psoriasis: the metabolic, clinical and therapeutic implications Report of an interdisciplinary conference and review.
        Br J Dermatol. 2007; 157: 649-655
        • Kaur S.
        • Zilmer K.
        • Kairane C.
        • Kals M.
        • Zilmer M
        Clear differences in adiponectin level and glutathione redox status revealed in obese and normal-weight patients with psoriasis.
        Br J Dermatol. 2008; 159: 1364-1367
        • Takahashi H.
        • Tsuji H.
        • Takahashi I.
        • Hashimoto Y.
        • Ishida-Yamamoto A.
        • Iizuka H.
        Plasma adiponectin and leptin levels in Japanese patients with psoriasis.
        Br J Dermatol. 2008; 159: 1207-1208
        • Frederiksson T.P.U.
        Severe psoriasis – oral therapy with a new retinoid.
        Dermatologica. 1978; 157: 238-244
        • Naldi L.
        • Gambini D.
        The clinical spectrum of psoriasis.
        Clin Dermatol. 2007; 25: 510-518
        • Niehaus Jr., W.G.
        • Samuelsson B.
        Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation.
        Eur J Biochem. 1968; 6: 126-130
        • Willerson J.T.
        • Ridker P.M.
        Inflammation as a cardiovascular risk factor.
        Circulation. 2004; 109 (II2 II10)
        • Sattar N.
        • Crompton P.
        • Cherry L.
        • Kane D.
        • Lowe G.
        • McInnes I.B.
        Effects of tumor necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis: a double-blind, placebo-controlled study.
        Arthritis Rheum. 2007; 56: 831-839